Paolo Dolzani, MSc

Photo of Paolo Dolzani, MSc
Paolo Dolzani, MSc
+39-051-6366093
+39-051-6366807

Personal information - Education and work experience

16/03/1964
Biologist

Biology Research Manager

1993: Biological Science degree, University of Modena, Italy.

2001: Specialist qualification in Clinical Pathology, University of Bologna, Italy.

  • From 2009: Senior Biology Research Manager, Laboratory of Immunology and Genetics, IOR, Bologna, Italy.
  • 1994-2008: Post-degree attendance, Laboratory of Immunology and Genetics, IOR, Bologna, Italy.

Basic English.

Windows O.S.; Office. Photoshop. Graph pad. Nikon NIS Elements (image analysis).

  • 1994–1997: Target research project of the Italian Health Ministry: A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B.
  • 1998-2000: Target research project of the Italian Health Ministry: Chondrocyte role in pathogenesis of cartilage damage in osteoarthritis and rheumatoid arthritis.
  • 2001: Target research project of the Italian Health Ministry: Tissue engineering in orthopedics.
  • 2002-2003: Target research project of the Italian Health Ministry: Biological and genetic Markers in Osteoarthritis.
  • 2004-2006: Target research project of the Italian Health Ministry: Influence of nutritional anti-oxidant factors, micro and macro nutrients on the immune response to inflammation in the elderly.
  • 2007-2008: Target research project of the Italian Health Ministry: Immune response to inflammation in the elderly pathology: inefficiency of anti-inflammatory pathways in Osteoarthritis”.

28 publications in journals with impact factors.

Immunohistopathology of synovial membrane. Pathophysiology of rheumatic and orthopedic diseases; particularly the role of cytokines and chemokines in cartilage and synovial tissue. Cell and organ cultures, chondrocyte separation, chondrocyte 3D cultures. Immunofluorescence and immunohistochemistry techniques.

Content updated 14/07/2016 - 14:38
Utilizza SharethisShareThis  Scrivi una email  Vai a facebook  Vai a twitter